(Circulation. 1995;91:794-801.)
© 1995 American Heart Association, Inc.
Articles |
Left Ventricular Performance and Remodeling in Rabbits After Myocardial Infarction
Effects of a Thyroid Hormone Analogue
From the Department of Internal Medicine, Veterans Administration Medical Center; and the University Heart Center, University of Arizona, Tucson, Ariz.
Correspondence to Dr Thomas E. Raya, Cardiology Section, 111C, Tucson Veterans Administration Medical Center, Tucson, AZ 85723.
Background Because the rat postinfarction model differs from human heart failure with respect to the composition of myosin heavy chain (MHC) isoforms and other contractile proteins, alternative animal models are needed for the development of new treatments for human heart failure. The purpose of this study was threefold: (1) to test the feasibility of using the V3(ß,ß) rabbit postinfarction model for the study of heart failure by characterizing the effects of chronic coronary artery occlusion on the left ventricle; (2) to determine whether the thyroid hormone analogue 3,5-diiodothyropropionic acid (DITPA) produces improvements in left ventricular function; and (3) to determine the effects of myocardial infarction and treatment with DITPA on MHC protein isoforms.
Methods and Results Male New Zealand White rabbits underwent
proximal circumflex coronary artery ligation. After infarction, rabbits
were treated with DITPA (3.75 mg/kg body wt) or placebo for 21 days and
then underwent conscious and open-chest hemodynamic studies. In
separate groups of rabbits, ß- and 
-MHC isoforms were separated,
and relative proportions were measured using gradient sodium dodecyl
sulfate–polyacrylamide gel electrophoresis and laser densitometry.
Infarction resulted in increased left ventricular
end-diastolic pressure and prolonged left ventricular
relaxation (
) (P=.001 for both variables). Postinfarction
treatment with DITPA decreased left ventricular
end-diastolic pressure and (P=.002 and
P=.001, respectively) and increased maximum positive and
negative dP/dt (P=.002 and P=.016,
respectively).
Infarcted rabbits treated with DITPA had no significant changes in
heart rate or left ventricular systolic pressure compared with
untreated rabbits with infarction. There were no significant
differences in heart rate, positive dP/dt, peak systolic pressure, or
between sham-operated rabbits and sham-operated rabbits treated
with DITPA. Although infarction resulted in increased left ventricular
diameter, there were no effects of DITPA on left ventricular
remodeling. Neither myocardial infarction nor treatment with DITPA
altered the ratio of MHC isoforms.
Conclusions Rabbits that survive occlusion of the circumflex artery will develop myocardial dysfunction and left ventricular remodeling. Therapy with DITPA, a thyroid hormone analogue, produces improvement in ventricular performance and reduces end-diastolic pressure. The hemodynamic effects of DITPA were not associated with alterations of MHC isoforms. Whether DITPA represents the prototype of a previously undescribed class of agents for the treatment of heart failure will need to be determined by clinical trials.
Key Words: 3,5-diiodothyropropionic acid • heart failure • thyroid • ventricles
This article has been cited by other articles:
 |
|
 |
|
  S. Goldman, M. McCarren, E. Morkin, P. W. Ladenson, R. Edson, S. Warren, J. Ohm, H. Thai, L. Churby, J. Barnhill, et al. DITPA (3,5-Diiodothyropropionic Acid), a Thyroid Hormone Analog to Treat Heart Failure: Phase II Trial Veterans Affairs Cooperative Study Circulation, June 23, 2009; 119(24): 3093 - 3100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liu, D. Wang, R. A. Redetzke, B. A. Sherer, and A. M. Gerdes Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1551 - H1557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Vargas, J. M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, and J. Garcia-Estan Vascular and renal function in experimental thyroid disorders Eur. J. Endocrinol., February 1, 2006; 154(2): 197 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kenessey and K. Ojamaa Ligand-mediated decrease of thyroid hormone receptor-{alpha}1 in cardiomyocytes by proteosome-dependent degradation and altered mRNA stability Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H813 - H821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Adamson, N. Maitra, J. Bahl, K. Greer, S. Klewer, J. Hoying, and E. Morkin Regulation of Gene Expression in Cardiomyocytes by Thyroid Hormone and Thyroid Hormone Analogs 3,5-Diiodothyropropionic Acid and CGS 23425 [N-[3,5-Dimethyl-4-(4'-hydroxy-3'-isopropylphenoxy)-phenyl]-oxamic Acid] J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 164 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zheng, R. M. Weiss, X. Wang, R. Zhou, A. M. Arlen, L. Lei, E. Lazartigues, and R. J. Tomanek DITPA stimulates arteriolar growth and modifies myocardial postinfarction remodeling Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1994 - H2000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F R Quinn, S Currie, A M Duncan, S Miller, R Sayeed, S M Cobbe, and G L Smith Myocardial infarction causes increased expression but decreased activity of the myocardial Na+--Ca2+ exchanger in the rabbit J. Physiol., November 15, 2003; 553(1): 229 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Nusz, D. C. White, Q. Dai, A. M. Pippen, M. A. Thompson, G. B. Walton, C. J. Parsa, W. J. Koch, and B. H. Annex Vascular rarefaction in peripheral skeletal muscle after experimental heart failure Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1554 - H1562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, W. Zheng, L. P. Christensen, and R. J. Tomanek DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H613 - H618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Friberg, S. Werner, G. Eggertsen, and S. Ahnve Rapid Down-regulation of Thyroid Hormones in Acute Myocardial Infarction: Is It Cardioprotective in Patients With Angina? Arch Intern Med, June 24, 2002; 162(12): 1388 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Preckel, W. Schlack, T. Heibel, and H. Rutten Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function Br. J. Anaesth., February 1, 2002; 88(2): 264 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ojamaa, A. Kenessey, R. Shenoy, and I. Klein Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1319 - E1324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. U. Trost, E. Swanson, B. Gloss, D. B. Wang-Iverson, H. Zhang, T. Volodarsky, G. J. Grover, J. D. Baxter, G. Chiellini, T. S. Scanlan, et al. The Thyroid Hormone Receptor-{beta}-Selective Agonist GC-1 Differentially Affects Plasma Lipids and Cardiac Activity Endocrinology, September 1, 2000; 141(9): 3057 - 3064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Wickenden, R. Kaprielian, X.-M. You, and P. H. Backx The thyroid hormone analog DITPA restores Ito in rats after myocardial infarction Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1105 - H1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Litwin, D. Zhang, P. Roberge, and G. D. Pennock DITPA prevents the blunted contraction-frequency relationship in myocytes from infarcted hearts Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H862 - H870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.A. McIntosh, S.M. Cobbe, and G.L. Smith Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure Cardiovasc Res, January 14, 2000; 45(2): 397 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Maurice, A. S. Shah, A. P. Kypson, J. A. Hata, D. C. White, D. D. Glower, and W. J. Koch Molecular beta -adrenergic signaling abnormalities in failing rabbit hearts after infarction Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1853 - H1860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Z. Atkins, C. W. Lewis, W. E. Kraus, K. A. Hutcheson, D. D. Glower, and D. A. Taylor Intracardiac transplantation of skeletal myoblasts yields two populations of striated cells in situ Ann. Thorac. Surg., January 1, 1999; 67(1): 124 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Skolnick, S. E. Litwin, W. H. Barry, and K. W. Spitzer Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1788 - H1797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. Lewis, B. Z. Atkins, K. A. Hutcheson, C. T. Gillen, M. C. Reedy, D. D. Glower, and D. A. Taylor A load-independent in vivo model for evaluating therapeutic interventions in injured myocardium Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1834 - H1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Litwin and J. H. B. Bridge Enhanced Na+-Ca2+ Exchange in the Infarcted Heart : Implications for Excitation-Contraction Coupling Circ. Res., December 19, 1997; 81(6): 1083 - 1093. [Abstract] [Full Text]
|
|
|
|
|
|
G. D. Pennock, D. D. Yun, P. G. Agarwal, P. H. Spooner, and S. Goldman Echocardiographic changes after myocardial infarction in a model of left ventricular diastolic dysfunction Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H2018 - H2029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Wildhirt, H. Suzuki, D. Horstman, S. Weismuller, R. R. Dudek, K. Akiyama, and B. Reichart Selective Modulation of Inducible Nitric Oxide Synthase Isozyme in Myocardial Infarction Circulation, September 2, 1997; 96(5): 1616 - 1623. [Abstract] [Full Text]
|
|